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Abstract 20 
Polycystic ovary syndrome (PCOS) affects over 10% of women. Insulin resistance, 21 
elevated free fatty acids (FFAs) and increased adiposity are key factors contributing 22 
to metabolic dysfunction in PCOS. We hypothesised that aberrant adipogenesis 23 
during adolescence, and downstream metabolic perturbations, contributes to the 24 
metabolic phenotype of adult PCOS. We used prenatally androgenized (PA) sheep as 25 
a clinically realistic model of PCOS. During adolescence, but not during fetal or early 26 
life of PA sheep, adipogenesis was decreased in subcutaneous adipose tissue (SAT) 27 
accompanied by decreased leptin, adiponectin, and increased FFAs. In adulthood, PA 28 
sheep developed adipocyte hypertrophy in SAT paralleled by increased expression of 29 
inflammatory markers, elevated FFAs and increased expression of genes linked to fat 30 
accumulation in visceral adipose tissue. This study provides better understanding into 31 
the pathophysiology of PCOS from puberty to adulthood and identifies opportunity for 32 
early clinical intervention to normalise adipogenesis and ameliorate the metabolic 33 
phenotype. 34 
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1. Introduction 39 
Polycystic ovary syndrome (PCOS) is a common disorder, affecting up to 10% of 40 
women of reproductive age (Fauser et al., 2012). Women with PCOS have increased 41 
risks of hyperinsulinemia, insulin resistance, obesity, dyslipidemia and fatty liver 42 
(Fauser et al., 2012; Moran et al., 2015; Teede et al., 2010). Metabolic comorbidities 43 
associated with the syndrome worsen with age and pose a significant health and 44 
economic burden (Jason, 2011; Teede et al., 2010).  45 
Overweight/obese women with PCOS have increased abdominal adiposity when 46 
compared with BMI-matched controls, correlated with an adverse metabolic profile 47 
(Puder et al., 2005; Yildirim et al., 2003). In addition, women with PCOS have 48 
adipose tissue dysfunction, independent of obesity (Carmina et al., 2005; Echiburú et 49 
al., 2018; Manneras-Holm et al., 2010; Seow et al., 2009; Wang et al., 2012). 50 
Although studies using animal models of PCOS have also indicated adipose tissue 51 
abnormalities, the data is inconclusive (Keller et al., 2014; Puttabyatappa et al., 52 
2018; Veiga-Lopez et al., 2013). Insulin and androgens, both typically increased in 53 
PCOS, affect adipogenesis and adipose tissue function (Chazenbalk et al., 2013; 54 
Klemm et al., 2001), and thus are likely to play an important role in adipose tissue 55 
dysfunction in PCOS. White adipose tissue (WAT) is a key metabolic and endocrine 56 
organ regulating energy homeostasis, insulin sensitivity and inflammation, therefore 57 
functional WAT is essential in maintaining body homeostasis (Lafontan, 2014). There 58 
is strong evidence showing differences between subcutaneous adipose tissue (SAT) 59 
and visceral adipose tissue (VAT) biology, including distinct gene expression in VAT 60 
and SAT preadipocytes (Macotela et al., 2012; Tchkonia et al., 2013) 61 
Animal models of PCOS are instrumental in dissecting mechanisms underlying the 62 
pathophysiology of PCOS (Abbott et al., 2013; Padmanabhan and Veiga-Lopez, 63 
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2013). We have previously documented that ewes exposed to increased androgens 64 
in utero manifest ovarian, hormonal and metabolic phenotypes reminiscent of PCOS 65 
(Hogg et al., 2011; 2012; Rae et al., 2013; Ramaswamy et al., 2016), and male 66 
offspring from such pregnancies display similar metabolic disturbances as seen in 67 
sons born to women with PCOS (Siemienowicz et al., 2019). We have reported that 68 
adult prenatally androgen-excess exposed (PA) sheep have increased body weight 69 
and are insulin resistant (Siemienowicz et al., 2020), while in adolescence those 70 
sheep are hyperinsulinemic and have increased fat accumulation in the liver, 71 
independent of body weight or central adiposity (Hogg et al., 2011). We 72 
hypothesised that the metabolic phenotype of PA sheep is associated with aberrant 73 
adipogenesis. Herein we investigate adipose tissue structure and function in 74 
adulthood and highlight aberrant adipogenesis in adolescence and its consequences 75 
in female PA sheep. 76 
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2. Materials and Methods 78 
2.1 Ethics statement 79 
All studies were approved by the UK Home Office and conducted under approved 80 
Project Licence PPL60/4401. The Animal Research Ethics Committee of The 81 
University of Edinburgh approved this study. The study was carried out in 82 
accordance with the relevant guidelines.   83 
2.2 Animals and tissues 84 
Animal husbandry, experimental protocols and tissue collection were performed as 85 
previously described (Hogg et al., 2012; 2011; Rae et al., 2013; Ramaswamy et al., 86 
2016). Scottish Greyface ewes were housed in groups in spacious enclosures and 87 
fed hay ad libitum. Ewes with a healthy body condition score (2.75-3) were 88 
synchronised with Chronogest (flugestone) sponges (Intervet Ltd, UK) and 89 
Estrumate (cloprostenol) injection (Schering Plough Animal Health, UK) and mated 90 
with Texel rams. Pregnancy was suggested by lack of estrous and confirmed by 91 
ultrasound scanning.  92 
In the maternal injection cohort (MI) pregnant ewes were randomised to twice weekly 93 
IM 100mg testosterone propionate (TP) in 1ml vegetable oil from day (D)62 to D102 94 
of D147 pregnancy or 1ml vegetable oil (control (C)). 95 
In pregnancies where fetal tissue was collected (D112: C=9; PA=4), ewes were 96 
sacrificed on D112 of gestation via barbiturate overdose.  The gravid uterus was 97 
immediately removed, fetal sex and weight recorded, and tissue of interest snap 98 
frozen and stored at -80C. 99 
In pregnancies carried to term, lambs were weaned at 3 months and fed hay or 100 
grass ad libitum until sacrifice at 11 weeks [juvenile (C=8; PA=8)]; 11 months, 101 
[adolescent (C=5; PA=9)] or 30 months [adult (C=11; PA=4)].  102 
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In the fetal injection cohort (FI), on day 62 and day 82 of gestation, mothers were 103 
randomised and anesthetised by initial sedation with 10 mg Xylazine (i.m. Rompun; 104 
Bayer PLC Animal Health Division, UK), followed by 2mg/kg Ketamine (i.v, Keteset; 105 
Fort Dodge Animal Health, UK).  All subsequent procedures were conducted under 106 
surgical aseptic conditions. Fetuses were injected via ultrasound guidance into the 107 
fetal flank with 20G Quinke spinal needle (BD Biosciences, UK) with following 108 
according to the treatment group: control (C; n=12), 0.2ml vehicle (vegetable oil); 109 
testosterone propionate (TP; n=7), 20mg TP in 0.2ml vehicle; diethylsilbesterol 110 
(DES; n=8), 4mg DES in 0.2ml vehicle; dexamethasone (DEX; n=11), 100g DEX in 111 
0.2ml vehicle. Justification of the rationale, timing and treatment doses have been 112 
published previously (Siemienowicz et al., 2019). Immediately after surgical 113 
procedure completion all pregnant ewes were given prophylactic antibiotics 114 
(Streptacare, Animalcare Ltd., UK, 1 ml/25 kg) and were then monitored during 115 
recovery; no adverse effects of these procedures were observed. Lambs were 116 
weaned at 3 months and fed hay or grass ad libitum and sacrificed in adolescence 117 
(11 months of age).  118 
Animals were sacrificed as described before (Hogg et al., 2011), omental tissue was 119 
carefully removed and weighed, and tissues of interest were fixed in Bouins solution 120 
for 24h, transferred to 70% ethanol and processed into paraffin wax and/or snap 121 
frozen and stored at -80C. Visceral adipose tissue was collected from omentum and 122 
subcutaneous adipose tissue from the groin area. 123 
2.3 Plasma analyte determination 124 
Concentrations of fasting plasma free fatty acids (FFAs), triglycerides (TGs), total 125 
cholesterol and high-density lipoprotein (HDL) were obtained using commercial 126 
assay kits (Alpha Laboratories Ltd., UK) as per manufacturer’s instruction, using a 127 
 7 
Cobas Mira automated analyser (Roche Diagnostics Ltd, UK). For all assays intra 128 
and inter-assay CV’s were < 4% CV and < 5% CV, respectively. Fasting plasma 129 
leptin concentration was measured using Bio-Plex Human Diabetes Assay 130 
(171A7001M; Bio-Rad, UK), as per the manufacturer’s instruction. All samples were 131 
assayed in duplicate and the results were acquired and calculated using Bio-Plex 132 
200 array reader system with Bio-Plex Manager software (Bio-Rad, UK). The assay 133 
working range for leptin was 0.011-129ng/ml, assay sensitivity 3.1pg/ml, and intra 134 
and inter-assay CVs were 3% and 4%, respectively. Plasma adiponectin was 135 
measured using human Adiponectin ELISA kit (KHP041; Invitrogen, Life 136 
Technologies, UK), as per the manufacturer’s instructions. All samples were assayed 137 
in duplicate. The assay sensitivity was 0.1ng/ml intra and inter-assay CVs were <5% 138 
and <6%, respectively. 139 
2.4 Adipocyte morphometric analysis 140 
For adipocyte morphometric analysis, two 5 m sections were cut per adipose tissue 141 
sample, a minimum of 100 m apart, and mounted on positively charged slides 142 
(Superfrost Plus Gold, Thermoscientific, UK). Sections were than stained with 143 
haematoxylin and eosin following standard protocol.  Two randomly selected fields 144 
per section were captured at X4 magnification using Olympus Provis BX2 145 
microscope (Olympus America Inc., USA) attached to a Canon EOS 30D Microcam 146 
camera (Canon Inc, Japan). Images were analysed using Adiposoft, ImageJ 147 
Software (Galarraga et al., 2012) in a blinded manner. Results were than manually 148 
corrected as per Adiposoft instructions and confirmed on a graticuled microscope.  149 
2.5 Western Blotting 150 
For western blotting all controls (C; n=5) and 5 samples from PA group were randomly 151 
selected for the analysis. Samples were homogenised with Soniprep150 (MSE UK 152 
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Ltd.) in RIPA buffer (ab156034, Abcam, UK) supplemented with HaltTM Protease 153 
Inhibitor Cocktail (Thermo Scientific Pierce, USA) and centrifuged at 17500g at 4°C 154 
for 10 min to pellet cellular debris. Protein concentration was measured using the 155 
Bradford Assay on Cobas Fara centrifugal analyser (Roche Diagnostics, UK). 156 
Samples were diluted in RIPA buffer and combined with equal volume of 1X Laemmli 157 
buffer (0.1M Tris-HCl pH 6.8, 20% glycerol, 2% (w/v) SDS, 0.16% (w/v) bromophenol 158 
blue and 3% β-mercaptoethanol). After heat denaturation (95oC for 5 min), samples 159 
(20 µg total protein) underwent electrophoresis, alongside full-range PageRulerTM 160 
Plus Prestained Protein Ladder (Thermo Scientific Pierce, USA),  on 4-20% Tris-161 
HEPES-SDS Precast Polyacrylamide Mini Gels (Thermo Scientific Pierce, USA) and 162 
were transferred to a PVDF membrane (IPFL00010; Immobilon-FL PVDF; Merck 163 
Millipore, Germany) using fast semi-dry blotter (Thermo Scientific Pierce, USA). 164 
Membranes were blocked in Odyssey Blocking Buffer (Li-Cor, USA) overnight at 4°C. 165 
Membrane was probed with  primary antibody raised against STAT1 (1:1000; SC-346, 166 
Santa Cruz Biotechnology) for 2h at RT, washed and probed with a primary antibody 167 
raised against PPARγ (1:500; SC-1984 Santa Cruz Biotechnology) for 4h at RT. After 168 
washing, membranes were incubated with two different fluorescently-labelled 169 
secondary antibodies at the concentration 1:10000 IRDye 680RD (926-68074; Li-Cor) 170 
and IRDye 800CW (926-32213; Li-Cor), both for 1h at RT. After final washing, 171 
membranes were visualised on the Odyssey Imager (Li-Cor, USA). The size of the 172 
visualised protein band was confirmed with reference to the molecular weight markers. 173 
Protein densitometry was analysed with Image Studio Lite Software (Li-Cor, USA) with 174 
STAT1 protein levels used as the loading control. 175 
2.5 Quantitative (q)RT-PCR 176 
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RNA was extracted from adipose tissue with a combination of TRI Reagent with the 177 
RNeasy Mini Kit (Qiagen Ltd.) and from liver using RNeasy Mini Kit following the 178 
manufacturer’s instructions. On-column DNase digestion was performed using 179 
RNase-Free DNase set (Qiagen Ltd.) and RNA concentration and purity was 180 
assessed using a NanoDrop One spectrometer (ThermoFisher Scientific, UK). 181 
Complimentary DNA was synthesised using TaqMan Reverse Transcription Kit 182 
(Applied Biosystems, UK) as described previously (Hogg et al., 2012). To select the 183 
most stable housekeeping genes the geNorm Reference Gene Selection Kit 184 
(Primerdesign Ltd., UK) was used, identifying in visceral adipose tissue the suitability 185 
of the geometric mean of RPS26 and 18S, and for subcutaneous adipose tissue and 186 
liver the geometric mean of ACTB and MDH1 was utilised. 187 
Primers (Table 1) were designed and synthesised as described previously 188 
(Siemienowicz et al., 2020). Real time RT-PCR was performed on 384-well plate 189 
format (Applied Biosystems) with all samples assayed in duplicate and 190 
housekeeping control genes included in each run, as well as template, RNA and RT-191 
negative controls, using the ABI 7900HT Fast Real Time PCR system (Applied 192 
Biosystems) as described previously (Hogg et al., 2012). The transcript abundance 193 
of target gene relative to the housekeeping genes was quantified using the Ct 194 
method (Livak and Schmittgen, 2001). 195 
2.6 Statistical analysis 196 
All data sets were normality tested prior to further analysis (Shapiro-Wilk test), and 197 
logarithmically transformed if necessary.  For comparing means of two treatment 198 
groups with equal variances, unpaired, two-tailed Student’s t test was used 199 
accepting P<0.05 as significant. For more than two comparisons ANOVA was used 200 
with Dunnett’s post hoc test. Correlation was assessed by calculation of Pearson 201 
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product-moment co-efficient. Statistical analysis was performed using GraphPad 202 
Prism 8.0 software (GraphPad Prism Software, San Diego, CA, USA).  Asterisks 203 
were used to indicate level of significance based on the following criteria: *P<0.05, 204 
**P<0.01. 205 
  206 
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3. Results 207 
3.1 PA sheep have structurally altered subcutaneous adipose tissue in 208 
adulthood  209 
Female PA sheep prenatally programmed to develop a PCOS-like condition show no 210 
difference in birth weight or body weight during the first year of life, through puberty 211 
and adolescence, however, in adulthood they have increased body weight as 212 
compared to controls (Siemienowicz et al., 2020). Adipocyte morphology was 213 
assessed by histological morphometric analysis (Fig. 1A). In VAT there was no 214 
difference in the numbers of adipocytes per mm2 (Fig. 1B), no change in the mean 215 
size of adipocytes (Fig. 1C) and no alteration the number of adipocytes of different 216 
sizes (Fig. 1D). In contrast, adipocyte number was decreased in SAT (Fig. 1E; 217 
P<0.05), with a trend to an augmented mean size of adipocytes (Fig. 1F; P=0.06) as 218 
a result of an increased number of large adipocytes (defined as larger than 5000 219 
µm2) (Fig. 1G; P<0.05). The increased number of large SAT adipocytes in PA sheep 220 
was not a consequence of increased body weight as the difference was also 221 
observed between a weight-matched subset of controls (n=4) and PA sheep (n=4) 222 
(Fig. 1H; P<0.05). Key transcriptional regulators of adipogenesis, PPARG, CEBPA, 223 
CEBPB and CEBPD were not altered in adult VAT or SAT (Fig. 1I). There are fewer, 224 
but larger adipocytes in SAT in PA sheep but this was not associated with alterations 225 
in adipogenesis in adulthood. 226 
3.2 Prenatal androgen excess is associated with adipose tissue dysfunction in 227 
adulthood 228 
There were no differences in the transcript abundance of markers of mature 229 
adipocytes (LEP and ADIPOQ) in VAT or SAT (Fig. 2A) in adult PA sheep. 230 
Furthermore, there was no difference in plasma concentrations (Fig. 2B,C), although 231 
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there was a trend towards decreased adiponectin level (Fig. 2C; P=0.08) in PA 232 
sheep when compared to controls. There were no differences in transcript 233 
abundance of inflammatory markers in VAT (Fig. 2D) while in SAT PA sheep had 234 
increased TNF (P<0.05), IL6 (P<0.05) and CCL2 (P<0.05) when compared to 235 
controls (Fig. 2E; P<0.05). Although the PA sheep have normal levels of TGs, 236 
cholesterol and HDL cholesterol (Fig. 3A-C) they have increased circulating FFAs 237 
(Fig. 3D; P<0.05). There was negative correlation (r= -0.66) between the total 238 
number of adipocytes per mm2 and the levels of circulating FFAs (Fig. 3E; P<0.05). 239 
Although at this time there was no difference in omental fat (Fig. 3F) there was 240 
increased transcript abundance of genes involved in fat uptake and accumulation in 241 
VAT (SLC27A1, CAV1, CAV2, FABP5 and LPIN2) (Fig. 3G-K; P<0.05). Alterations in 242 
adipose tissue associated with inflammation is seen in SAT only and this is 243 
associated with increased FFAs. In summary, we observed structurally altered 244 
subcutaneous adipose tissue, with attendant dysfunction in adulthood attributable to 245 
prenatal androgen excess.  246 
3.3 Altered adipogenesis is observed during adolescence 247 
We next assessed expression of transcription factors involved in adipogenesis at 11 248 
months of age when there was no difference in body weight (Siemienowicz et al., 249 
2020) and omental fat weight (Hogg et al., 2011). In VAT there was no difference in 250 
the transcript abundance of PPARG, CEBPA and CEBPB, although CEBPD was 251 
increased (P<0.05) in adolescent PA sheep (Fig. 4A). However, in SAT there was 252 
decreased transcript abundance of PPARG, CEBPA, CEBPB (Fig. 4B; P<0.05) but 253 
no difference in CEBPD (Fig. 4B). We confirmed decreased level of PPARG in SAT 254 
(Fig. 4C; P<0.05) in adolescent PA females, by Western blot. In addition, adolescent 255 
PA sheep had decreased expression of markers of mature adipocytes in SAT, 256 
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SLC2A4 and PLIN1 (Supplementary Figure 1; P<0.05-0.01). In order to determine 257 
the specificity of prenatal androgens in the regulation of adolescent adipogenesis 258 
(Fig. 4D) we directly injected various steroids into the mid-gestation fetus and 259 
assessed adipogenesis markers in SAT in adolescence. Reduced adipogenesis-260 
associated gene expression in SAT was only associated with prenatal androgen 261 
excess (TP) and neither estrogenic (DES) excess nor glucocorticoid (DEX) excess 262 
showed similar effects (Fig. 4D; P<0.05).  263 
3.4 Adolescent SAT transcriptional alterations are associated with increased 264 
circulating FFA  265 
Fasting FFAs were increased in adolescent PA sheep when compared to controls 266 
(Fig. 5A; P<0.05). Their concentrations were negatively correlated with PPARG (r=-267 
0.55) in SAT (Fig. 5B; P<0.05) but not with PPARG in VAT (Fig. 5C). These sheep 268 
have early accumulation of fat in the liver (Hogg et al., 2011) with increased 269 
transcript abundance of genes involved in FFAs uptake and deposition in the liver 270 
(Fig. 5D-F; P<0.05).  271 
3.5 Adiponectin is a biomarker of reduced SAT adipogenesis during 272 
adolescence 273 
To investigate potential biomarkers of altered adipogenesis during adolescence the 274 
transcript abundance of markers of mature adipocytes was investigated in adipose 275 
tissue at 11 months of age in control and PA animals. In VAT there was no changes 276 
in LEP or ADIPOQ expression (Fig. 6A,B). In contrast LEP (P<0.01) and ADIPOQ 277 
(P<0.05) were reduced in SAT in adolescent PA sheep when compared to controls 278 
(Fig. 6C,D). This was reflected by a reduction in circulating leptin (Fig 6E; P<0.05) 279 
and adiponectin (Fig. 6F; P<0.05) in the plasma. Circulating adiponectin correlated 280 
(r=0.79) to ADIPOQ in SAT (Fig. 6G; P<0.01) but not VAT (Fig. 6H), and there was 281 
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no correlation identified between circulating leptin and SAT LEP gene expression.  282 
Collectively, in female PA offspring, we observed altered adipogenesis during 283 
adolescence, with increased circulating FFA, and this response was specific to 284 
androgenic excess during development. Reduced circulating adiponectin has 285 
potential as a biomarker of reduced adipogenesis in SAT during adolescence. 286 
3.6 There is no evidence of altered adipogenesis before puberty 287 
Altered transcript abundance for transcription factors involved in adipogenesis was 288 
not observed pre-pubertally at 11 weeks of age or in fetal life (Table 1).  289 
  290 
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4. Discussion 291 
We demonstrated, using an ovine model of PCOS, that during adolescence, but not 292 
fetal or prepubertal life, there was decreased adipogenesis in SAT in PA sheep. This 293 
was accompanied by decreased concentrations of leptin and adiponectin, and 294 
increased concentrations of FFAs, likely underpinning the observation of upregulated 295 
expression of FFAs transporters in liver. Adult consequences of such altered 296 
adolescent adipogenesis were that PA female offspring displayed adipocyte 297 
hypertrophy in SAT paralleled by increased expression of inflammatory markers and 298 
increased expression of genes linked to fat accumulation in VAT.  299 
 300 
In fetal life pre-adipocyte differentiation into adipocytes occurs between the 14th and 301 
the 16th weeks of gestation in humans (Poissonnet et al., 1983) and in the third 302 
month of gestation in sheep (Wensvoort, 1967). In late gestation adipocyte 303 
proliferation decreases, and until adolescence, increased adiposity primarily occurs 304 
via filling of predetermined adipocytes. During puberty another window of adipocyte 305 
proliferation occurs (Rosen and Spiegelman, 2014) setting the total number of 306 
adipocytes. Whilst differentiation potential of pre-adipocytes into mature adipocytes 307 
is present throughout life, dependent upon energy status and storage needs (Rosen 308 
and Spiegelman, 2014), in adult life, the capacity of preadipocytes to become fully 309 
functional mature adipocytes declines (Tchkonia et al., 2010). Hence increased or 310 
decreased adult body weight, with corresponding fluctuations in body fat mass, is 311 
reflective of changes in adipocyte volume but not number (MacLean et al., 2015; 312 
Spalding et al., 2008).  In our study altered adipogenesis in SAT of PA females was 313 
only evident during adolescence (11 months).  314 
 315 
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During adipogenesis, pre-adipocyte terminal differentiation to mature adipocytes 316 
involves accruing lipid transport and synthesis capacity, insulin responsiveness and 317 
synthesis of adipokines, regulated by PPARG and the family of CCAAT/enhancer 318 
binding protein transcription factors (C/EBP) (Cristancho and Lazar, 2011). SAT 319 
expansion improves lipid buffering and metabolic profile (Kim et al., 2007) while 320 
inability to increase adipose cell number results in hypertrophic adipocytes, 321 
increasing risk of metabolic diseases (Dubois et al., 2006). Impaired SAT 322 
adipogenesis results in decreased storage capacity, and accumulation of lipids in 323 
non-adipose tissues, lipotoxicity and metabolic perturbations (Carobbio et al., 2017). 324 
Furthermore, decreased subcutaneous pre-adipocyte differentiation and defective 325 
storage capacity of SAT are associated with increased visceral adiposity (Alligier et 326 
al., 2013; Lessard et al., 2014), suggesting increased visceral fat accumulation might 327 
be a compensatory adaptation to limitations in SAT expandability (Britton and Fox, 328 
2011).  329 
 330 
Decreased expression of PPARG, CEBPA and CEBPB in SAT, in PA sheep 331 
suggests decreased differentiation of pre-adipocytes into mature adipocytes and 332 
indicates lower capacity of SAT to safely store fat, which combined with observations 333 
of  increased levels of FFAs in PA adolescent sheep supports suggestions of 334 
decreased lipid storage volume in SAT. This may also contribute to fatty liver 335 
development due to increased release of FFAs into circulation and increased hepatic 336 
uptake (Hogg et al., 2011). Morphometric analysis of the SAT in adolescent sheep 337 
was not performed due to lack of histological samples, as the aim of the study was to 338 
determine adult outcomes in terms of adipose structure, and examine the earlier life 339 
mechanistic antecedents of any altered adult structure observed; we acknowledge 340 
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this limitation of the data presented here. Veiga-Lopez et al.  previously reported that 341 
postpubertal, (21 months old), prenatally androgenised female sheep showed 342 
reduction in adipocyte cell size in both VAT and SAT and concluded failure of a 343 
subset of small adipocytes to differentiate. (Veiga-Lopez et al., 2013). We did not 344 
observe any effect on VAT in our adolescent animals. The discrepancies between 345 
studies may be attributed to different timing of the prenatal testosterone treatment 346 
and different age at study.  347 
Adipogenesis in PCOS patients has not been thoroughly investigated, however, 348 
increased abdominal adipose stem cell commitment to preadipocytes in vitro, as 349 
measured by the expression of ZFP423 protein, have been found in adult, normal 350 
weight women with PCOS (Fisch et al., 2018). Increased ZFP423 gene expression 351 
was also reported in abdominal SAT of prenatally androgenised female rhesus 352 
monkeys (Keller et al., 2014). We did not study the preadipocyte commitment but 353 
rather, the differentiation of preadipocytes into mature adipocytes. In agreement with 354 
our study, it was reported that women with PCOS have decreased expression and 355 
increased DNA methylation of PPARG in SAT and PPARG expression positively 356 
correlated with insulin sensitivity and negatively with adipocyte size and testosterone 357 
levels (Kokosar et al., 2016). Furthermore, PCOS-like monkeys were also have 358 
decreased abdominal SAT CEBPA expression, reduced numbers of mature SAT 359 
adipocytes and increased FFAs indicating impaired adipogenesis (Keller et al., 360 
2014). In addition, there is growing evidence of decreased adipogenesis in SAT from 361 
insulin resistant individuals and subjects with abdominal obesity (Heilbronn et al., 362 
2004; Permana et al., 2004; Yang et al., 2004). Our data is in broad agreement with 363 
such observations, lending translational confidence to our findings. 364 
 365 
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Further translational relevance in terms of PCOS is derived from observations that 366 
obese adolescent girls with PCOS have persistently elevated FFAs when compared 367 
with obese controls (King et al., 2017).  Since SAT represents approximately 80% of 368 
total body adipose tissue, decreased SAT adipogenesis in adolescence may 369 
predispose to decreased storage capacity in adulthood and increased adipocyte 370 
hypertrophy. In support of this, our adult PA sheep have decreased SAT adipocyte 371 
numbers and corresponding increased numbers of large, hypertrophic adipocytes, 372 
and adult PCOS women have hypertrophic adipocytes in SAT (Echiburú et al., 2018; 373 
Faulds et al., 2003; Manneras-Holm et al., 2010).  374 
 375 
Hypertrophic expansion of SAT is associated with altered adipokine secretion, 376 
inflammation and fibrosis (Longo et al., 2019). Adipocyte hypertrophy in adult PA 377 
sheep was paralleled by increased expression of TNF, IL6 and CCL2 in SAT. 378 
Enlarged adipocytes overexpress MCP-1 (encoded by CCL2 gene) and induce 379 
increased recruitment of proinflammatory M1 macrophages culminating in increased 380 
production of pro-inflammatory cytokines TNFα and IL-6, promoting altered gene 381 
expression and insulin resistance in adipocytes (Weisberg et al., 2003).  382 
 383 
Adolescent PA sheep had also decreased expression of markers of mature 384 
adipocytes LEP and ADIPOQ in SAT, functionally realised by decreased circulating 385 
leptin and adiponectin concentrations. There was positive correlation of ADIPOQ 386 
mRNA in SAT, with circulating adiponectin, reminiscent of that observed in women 387 
with PCOS (Echiburú et al., 2018; Lecke et al., 2013), and suggesting the likelihood 388 
that decreased adiponectin levels in adolescent PCOS-like sheep is a consequence 389 
of decreased adipogenesis in SAT. Adiponectin, primarily secreted from SAT, is an 390 
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insulin sensitising adipokine, promoting lipid oxidation and reducing plasma 391 
concentration of FFAs (Achari and Jain, 2017), and stimulates glucose uptake in 392 
adipocytes by increasing expression of GLUT4 (Achari and Jain, 2017; Fu et al., 393 
2005).  394 
 395 
Adiponectin is also an autocrine factor promoting and regulating adipocyte 396 
differentiation (do Carmo Avides et al., 2008; Fu et al., 2005). Decreased circulating 397 
adiponectin levels, independent of adiposity, are consistently reported in adolescent 398 
and adult PCOS patients (Cankaya et al., 2014; Escobar-Morreale et al., 2006; 399 
Maliqueo et al., 2012; Mirza et al., 2014; Sepilian and Nagamani, 2005), suggesting 400 
potential utility as a biomarker of PCOS (Al-Awadi et al., 2016; Sarray et al., 2015). 401 
Whilst androgens decrease plasma adiponectin in vitro and in vivo (Frederiksen et 402 
al., 2012; Nishizawa et al., 2002; Xu et al., 2005), and this is inversely correlated with 403 
testosterone levels, (Böttner et al., 2004; Riestra et al., 2013), to our knowledge this 404 
is the first demonstration of prenatal androgen excess being associated with 405 
decreased SAT and circulating adiponectin. It is noteworthy in the context of prenatal 406 
androgenic programming of PCOS that adiponectin decreases ovarian thecal 407 
androgen synthesis and expression of adiponectin receptors is decreased in theca 408 
cells from polycystic ovaries; consequently decreased adiponectin may also 409 
contribute to hyperandrogenism in PCOS women (Comim et al., 2013; Lagaly et al., 410 
2008). 411 
 412 
Inhibitory effects of androgens on adipogenesis is well documented (Zerradi et al., 413 
2014). Numerous studies demonstrate androgens prevent in vitro differentiation and 414 
proliferation of murine preadipocyte cell lines (Fujioka et al., 2012; Singh et al., 2003; 415 
 20 
2005) and human preadipocytes from both sexes, and from different fat depots 416 
(Blouin et al., 2010; Chazenbalk et al., 2013; Gupta et al., 2008; McNelis et al., 417 
2013). To determine steroid specificity of androgenic excess in programming 418 
adipose tissue function in vivo, we assessed SAT adipogenesis in adolescent, 11 419 
months old female sheep, that were directly injected in utero with androgen, 420 
estrogen (DES as surrogate estrogen) or glucocorticoid (DEX as surrogate, active 421 
glucocorticoid). We found that only androgen treatment, but not estrogen or 422 
glucocorticoid, decreased adipogenesis in SAT in adolescence, identifying that the 423 
responses measured throughout the study were androgenic. 424 
 425 
In summary, we have shown that during adolescence, altered adipogenesis in SAT 426 
of PA sheep occurs, with decreased beneficial adipokines, independent of central 427 
adiposity. Decreased adipocyte differentiation during adolescence resulted in 428 
hypertrophy and inflammation of adult SAT. This decreased capacity of SAT to 429 
safely store fat may explain metabolic perturbations observed in PA female sheep, 430 
shedding light upon new investigatory, and interventional avenues in clinical PCOS 431 
research.  432 
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E F G H
I
Transcriptional regulators of adipogenesis
Visceral adipose tissue Subcutaneous adipose tissue
Gene C PA P C PA P 
PPARG 0.88 ± 0.25 1.09 ± 0.53 n.s. 1.07 ± 0.41 0.87 ± 0.32 n.s.
CEBPA 1.06 ± 0.43 1.18 ± 0.53 n.s. 1.05 ± 0.38 1.22 ± 0.38 n.s.
CEBPB 1.09 ± 0.47 1.25 ± 0.55 n.s. 1.04 ± 0.30 1.07 ± 0.03 n.s.





































































































































































































































Figure 1. Adipose tissue analysis in adult (30M) controls (C; n=11) and prenatally 809 
androgenised sheep (PA; n=4). (A) Histological analysis of adipocyte morphology in 810 
VAT and SAT (C=8; PA=4) (scale bars = 100µm). (B) In VAT there was no 811 
difference in the numbers of adipocytes per mm2, (C) no difference in the mean size 812 
of adipocytes and (D) no alteration the number of adipocytes of different sizes. (E) 813 
PA sheep had decreased number of adipocytes in SAT, (F) with a trend to an 814 
augmented mean size of adipocytes and (G) increased number of large adipocytes. 815 
(H) The increased number of large SAT adipocytes in PA sheep was still seem when 816 
compared to a subset of obese controls (n=4). (I) There was no difference in the 817 
expression of PPARG, CEBPA, CEBPB and CEBPD in adult VAT or SAT. Box plot 818 
whiskers are lowest and highest observed values, box is the upper and lower 819 
quartile, with median represented by line in box. Data in the table represent mean ± 820 
standard deviation. Unpaired, two-tailed Student’s t test was used for comparing 821 
means of two treatment groups with equal variances accepting P<0.05 as significant. 822 




Markers of mature adipocytes
Visceral adipose tissue
Gene C PA P
LEP 1.07 ± 0.39 1.22 ± 0.57 n.s.
ADIPOQ 1.09 ± 0.52 1.56 ± 0.97 n.s.
Gene Subcutaneous adipose tissue
LEP 1.07 ± 0.43 1.29 ± 0.50 n.s.










































































































































































Figure 2. Adipose tissue function in adult (30M) controls (C; n=11) and prenatally 826 
androgenised sheep (PA; n=4). (A) There were no differences in LEP and ADIPOQ 827 
expression in VAT or SAT. (B) There was no difference in the circulating leptin 828 
between controls and PA sheep. (C) There was a trend towards decreased 829 
adiponectin level in PA sheep. (D) There were no differences in transcript 830 
abundance of inflammatory markers in VAT. (E) In SAT PA sheep had increased 831 
TNF, IL6 and CCL2 when compared to controls. Box plot whiskers are lowest and 832 
highest observed values, box is the upper and lower quartile, with median 833 
represented by line in box. Data in the table represent mean ± standard deviation. 834 
Unpaired, two-tailed Student’s t test was used for comparing means of two treatment 835 


















































































































































































































































Figure 3. Metabolic function in adult (30M) controls (C; n=11) and prenatally 839 
androgenised sheep (PA; n=4). PCOS-like sheep have normal levels of (A) 840 
triglycerides, (B) cholesterol and (C) HDL cholesterol and (D) increased circulating 841 
FFAs. (E) There was negative correlation between the total number of adipocytes 842 
per mm2 and the levels of circulating FFAs. (F) At this time there was no difference in 843 
omental fat between controls and PA sheep, however there was increased transcript 844 
abundance of genes involved in fat uptake and accumulation in VAT (G) SLC27A1, 845 
(H) CAV1, (I) CAV2, (J) FABP5 and (K) LPIN2. Box plot whiskers are lowest and 846 
highest observed values, box is the upper and lower quartile, with median 847 
represented by line in box. Unpaired, two-tailed Student’s t test was used for 848 
comparing means of two treatment groups with equal variances accepting P<0.05 as 849 
significant. Correlation was assessed by calculation of Pearson product-moment co-850 




Figure 4. Transcript abundance of adipogenesis markers in adolescent (11M) 854 
controls (C; n=5) and prenatally androgenised sheep (PA; n=9). (A) In VAT there 855 




























































































































































































































































































although CEBPD was increased. (B) Prenatally androgenised sheep had decreased 857 
adipogenesis in SAT with a reduction in the transcript abundance of PPARG, 858 
CEBPA, CEBPB and no difference in CEBPD. (C) Decreased level of PPARG in 859 
SAT in prenatally androgenised females was confirmed with western blot. (D). As 860 
compared with controls (C; n=12), the transcript abundance of adipogenesis markers 861 
in SAT was decreased by directly injected androgens in fetal life (TP; n=7) but not 862 
estrogens (DES; n=8) or glucocorticoids (DEX; n=11). Box plot whiskers are lowest 863 
and highest observed values, box is the upper and lower quartile, with median 864 
represented by line in box. Unpaired, two-tailed Student’s t test was used for 865 
comparing means of two treatment groups with equal variances accepting P<0.05 as 866 
significant. Unpaired, one-tailed Student’s t test was used for western blot analysis. 867 
For more than two comparisons ANOVA was used with Dunnett’s post hoc test. 868 




Figure 5. Adipose tissue function in adolescent (11M) controls (C; n=5) and 872 
prenatally androgenised sheep (PA; n=9). (A) Adolescent prenatally androgenised 873 
sheep had increased fasting FFA. (B) Concentration of FFAs negatively correlated 874 
with PPARG (r=-0.55) in SAT but not (C) with PPARG in VAT. There is increased 875 
transcript abundance of (D) SLC27A2, (E) SLC27A5 and (F) CAV2 involved in 876 
hepatic fat uptake. Box plot whiskers are lowest and highest observed values, box is 877 
the upper and lower quartile, with median represented by line in box. Unpaired, two-878 
tailed Student’s t test was used for comparing means of two treatment groups with 879 
equal variances accepting P<0.05 as significant. Correlation was assessed by 880 




























































































































Figure 6. Transcript abundance and circulating levels of leptin and adiponectin in 884 
adolescent (11M) controls (C; n=5) and prenatally androgenised sheep (PA; n=9). In 885 
VAT there was no difference in the expression of (A) LEP or (B) ADIPOQ. 886 
Adolescent prenatally androgenised sheep had decreased expression of (C) LEP 887 
and (D) ADIPOQ in SAT. This was mirrored by a reduction in circulating (E) leptin 888 
and (F) adiponectin in PA sheep. (G) Circulating adiponectin correlated (r=0.79) with 889 
ADIPOQ expression in SAT but not (H) in VAT. Box plot whiskers are lowest and 890 
highest observed values, box is the upper and lower quartile, with median 891 
represented by line in box. Unpaired, two-tailed Student’s t test was used for 892 
comparing means of two treatment groups with equal variances accepting P<0.05 as 893 
significant. Correlation was assessed by calculation of Pearson product-moment co-894 
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 897 
Supplementary Figure 1. Transcript abundance of markers of mature adipocytes in 898 
adolescent (11M) controls (C; n=5) and prenatally androgenised sheep (PA; n=9). 899 
(A) In VAT there was no difference in the transcript abundance of SLC2A4, PLIN1 900 
and LPL. (B) Prenatally androgenised sheep had decreased expression of SLC2A4 901 
and PLIN1 in SAT with no difference in LPL. Box plot whiskers are lowest and 902 
highest observed values, box is the upper and lower quartile, with median 903 
represented by line in box. Unpaired, two-tailed Student’s t test was used for 904 
comparing means of two treatment groups with equal variances accepting P<0.05 as 905 
significant. (*P<0.05; ** P<0.01).  906 



































































































































Table 1 908 
 909 
Transcriptional regulators of 
adipogenesis 
Subcutaneous adipose tissue 
Fetal life (D112) 
Gene C TP P  
PPARG 1.29 ± 0.85 1.75 ± 0.39 n.s. 
CEBPA 1.26 ± 0.79 1.42 ± 0.63 n.s. 
CEBPB 1.21 ± 0.72 1.17 ± 0.55 n.s. 
CEBPD 1.05 ± 0.35 1.09 ± 0.19 n.s. 
Gene Pre-pubertal (11 weeks) 
PPARG 1.03 ± 0.25 1.30 ± 0.46 n.s. 
CEBPA 1.11 ± 0.51 1.47 ± 0.63 n.s. 
CEBPB 1.01 ± 0.33 1.34 ± 0.38 n.s. 
CEBPD 1.04 ± 0.28 0.90 ± 0.33 n.s. 
 910 
Table 1. Timing of altered adipogenesis. There was no difference in the expression 911 
of transcription factors involved in adipogenesis in fetal life at GD112 (C; n=9; PA; 912 
n=4) or in pre-pubertal sheep at 11 weeks of age (C; n=8; PA; n=8). Data in the table 913 
represent mean ± standard deviation. Unpaired, two-tailed Student’s t test was used 914 
for comparing means of two treatment groups with equal variances accepting P<0.05 915 
as significant.  916 
 917 
 49 
Supplementary Table 1 918 
 919 
Supplementary Table 1. Primers for real-time RT-PCR analysis. Forward and 920 
reverse primers were designed using Primer3 Input version 0.4 online software 921 
(http://frodo.wi.mit.edu) with DNA sequences obtained at Ensembl Genome Browser. 922 
To confirm the validity of the gene product in the sheep, both conventional PCR and 923 
amplicon sequencing were performed. Primer specificity and efficacy for qRT-PCR 924 
was evaluated through the generation of standard curves with serial dilutions of 925 
Gene Forward Primer Reverse Primer 
18S CAACTTTCGATGGTAGTCG CCTTCCTTGGATGTGGTA 
ACTB ATCGAGGACAGGATGCAGAA CCAATCCACACGGAGTACTTG 
ADIPOQ AGAGATGGCACCCCTGGT GACCTTCGATCCCAGTGATT 
ADIPOR1 TCTCCTGGCTCTTCCACACT AGCTCCCCATGATCAGCA 
ADIPOR2 AGGTCGGGAGCCTCTTGTAG TGAACCCCTCATCTTCCTGA 
CAV1 CATCTCTACACTGTTCCCATCC ACGTCGTCGTTGAGATGCTT 
CAV2 CCACAGCAGCGTCGATTAC CACTGGCTCTGCAATCACAT 
CCL2 GACCCCAACCTGAAATGGGT GCAGTTAGGGGAAGCCAGAA 
CEBPA GTGGACAAGAACAGCAACGA CGCAGTGTGTCCAGTTCG 
CEBPB GACAAGCACAGCGACGAGTA AGCTGCTCCACCTTCTTCTG 
CEBPD CGAGTACCGGCAGCGAC GTCGCGCAGTCCGGC 
FABP5 TTCAGCAGCTGGTAGGAAGA GCACCTACTTTTCGCAGAGC 
IL6 AAATGACACCACCCCAAGCA CTCCAGAAGACCAGCAGTGG 
INSR CACCATCACTCAGGGGAAAC CAGGAGGTCTCGGAAGTCAG 
IRS1 ATCATCAACCCCATCAGACG GAGTTTGCCACTACCGCTCT 
IRS2 TCCAGAACGGCCTCAACTAC TCAGGTGATGCGTCAAGAAG 
LEP ATCTCACACACGCAGTCCGT CCAGCAGGTGGAGAAGGTC 
LPIN2 GACGTCACCCTGTCACTCTG GAGTCCAGGGTTTTCTGCAA 
MDH1 TTATCTCCGATGGCAACTCC GGGAGACCTTCAACAACTTTCC 
PPARG TGCAGTGGGGATGTCTCATA CAGCGGGAAGGACTTTATGT 
RPS26 CAAGGTAGTCAGGAATCGCTCT TTACATGGGCTTTGGTGGAG 
SLC27A2 GTGGAAAGGGGAAAATGTGG TCAAATTCATGGTCTGCCTTC 
SLC27A5 CGGACATCAAGTTGCGAAG ATCCCTGATACCTGCAGCAC 
SLC2A4 CCAGCATCTTTGAGTCAGCA CAGAAGCAGAGCCACAGTCA 
TNF GGTGCCTCAGCCTCTTCT   GAACCAGAGGCCTGTTGAAG   
 50 
cDNA; a standard curve slope of approximately -3.3 was accepted as efficient, and a 926 
melt-curve analysis was also performed. 927 
